These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28478211)

  • 1. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
    Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D
    Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.
    Rolain JM; Boulos A; Mallet MN; Raoult D
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2673-6. PubMed ID: 15980335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media.
    Smith CB; Evavold C; Kersh GJ
    Sci Rep; 2019 Dec; 9(1):18132. PubMed ID: 31792307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.
    Rolain JM; Lambert F; Raoult D
    Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rifapentine and other rifamycins against
    Miller HK; Kersh GJ
    Microbiol Spectr; 2024 Jul; 12(7):e0103424. PubMed ID: 38864598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of axenic media to determine antibiotic efficacy against coxiella burnetii.
    Clay KA; Hartley MG; Russell P; Norville IH
    Int J Antimicrob Agents; 2018 May; 51(5):806-808. PubMed ID: 28802854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis.
    Rolain JM; Mallet MN; Raoult D
    J Infect Dis; 2003 Nov; 188(9):1322-5. PubMed ID: 14593588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis.
    Lecaillet A; Mallet MN; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Apr; 63(4):771-4. PubMed ID: 19218274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR.
    Boulos A; Rolain JM; Maurin M; Raoult D
    Int J Antimicrob Agents; 2004 Feb; 23(2):169-74. PubMed ID: 15013043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii.
    Andoh M; Naganawa T; Yamaguchi T; Fukushi H; Hirai K
    Microbiol Immunol; 2004; 48(9):661-4. PubMed ID: 15383702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells.
    Raoult D; Drancourt M; Vestris G
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1512-4. PubMed ID: 2221859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of intracellular Coxiella burnetii to antimicrobial peptides in mouse fibroblast cells.
    Unsworth NB; Dawson RM; Wade JD; Liu CQ
    Protein Pept Lett; 2014; 21(2):115-23. PubMed ID: 24364858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
    Raoult D; Torres H; Drancourt M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2070-7. PubMed ID: 1759829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 18. Sternoclavicular joint infection caused by Coxiella burnetii: a case report.
    Angelakis E; Thiberville SD; Million M; Raoult D
    J Med Case Rep; 2016 May; 10(1):139. PubMed ID: 27246557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary inflammatory pseudotumor due to Coxiella burnetii. Case report and literature review.
    Polo MF; Mastrandrea S; Santoru L; Arcadu A; Masala G; Marras V; Bagella G; Sechi MM; Tanda F; Pirina P
    Microbes Infect; 2015; 17(11-12):795-8. PubMed ID: 26342254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IS1111 insertion sequence used for detection of Coxiella burnetii is widespread in Coxiella-like endosymbionts of ticks.
    Duron O
    FEMS Microbiol Lett; 2015 Sep; 362(17):fnv132. PubMed ID: 26269380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.